TY - JOUR
T1 - Highly sensitive and portable aptasensor by using enzymatic nanoreactors as labels
AU - Yang, Liting
AU - Wang, Yin
AU - Yao, Cheng
AU - Xu, Xuan
N1 - Publisher Copyright:
© 2021
PY - 2021/9
Y1 - 2021/9
N2 - Due to the extremely low concentration of many small molecular targets, improving the sensitivity of aptasensors is urgently needed. Herein, a highly sensitive and portable biosensing platform of Fe3O4@Au-Apt/DMSNs-I-cDNA is designed on magnetic Fe3O4@Au by using enzymatic nanoreactors as signal labels. This signal label is prepared by encapsulating invertase into dendritic mesoporous silica nanoparticles (DMSNs-I), resulting in large enzyme load amount (407.3 ± 28 mg g−1) and high bioactivity recovery (78.56%). Therefore, DMSNs-I can efficiently convert sucrose into glucose with personal glucose meter (PGM) as readout. Under PGM assay mode, this sensing platform achieves accurate recognition and sensitive detection of aflatoxin B1 (AFB1) and bisphenol A (BPA) with low detection limits of 0.74 pg mL−1 and 0.094 pM (S/N = 3), respectively. Compared with the single invertase labelled aptasensor, the DMSNs-I labelled AFB1 aptasensor achieves ~3.19 times enhancement of sensitivity and 2 orders of magnitude lower in the detection limit. In addition, the proposed aptasensors are applied to detect AFB1 and BPA in complex samples with the acceptable recovery values. They also exhibited good selectivity and high stability, indicating the potential of the Fe3O4@Au-Apt/DMSNs-I-cDNA biosensing platform in constructing highly sensitive aptasensors for detecting small molecules.
AB - Due to the extremely low concentration of many small molecular targets, improving the sensitivity of aptasensors is urgently needed. Herein, a highly sensitive and portable biosensing platform of Fe3O4@Au-Apt/DMSNs-I-cDNA is designed on magnetic Fe3O4@Au by using enzymatic nanoreactors as signal labels. This signal label is prepared by encapsulating invertase into dendritic mesoporous silica nanoparticles (DMSNs-I), resulting in large enzyme load amount (407.3 ± 28 mg g−1) and high bioactivity recovery (78.56%). Therefore, DMSNs-I can efficiently convert sucrose into glucose with personal glucose meter (PGM) as readout. Under PGM assay mode, this sensing platform achieves accurate recognition and sensitive detection of aflatoxin B1 (AFB1) and bisphenol A (BPA) with low detection limits of 0.74 pg mL−1 and 0.094 pM (S/N = 3), respectively. Compared with the single invertase labelled aptasensor, the DMSNs-I labelled AFB1 aptasensor achieves ~3.19 times enhancement of sensitivity and 2 orders of magnitude lower in the detection limit. In addition, the proposed aptasensors are applied to detect AFB1 and BPA in complex samples with the acceptable recovery values. They also exhibited good selectivity and high stability, indicating the potential of the Fe3O4@Au-Apt/DMSNs-I-cDNA biosensing platform in constructing highly sensitive aptasensors for detecting small molecules.
KW - Aflatoxin B1
KW - Bisphenol A
KW - Dendritic mesoporous silica nanoparticles
KW - Enzymatic nanoreactor
KW - Invertase
KW - Signal amplification
UR - http://www.scopus.com/inward/record.url?scp=85106377220&partnerID=8YFLogxK
U2 - 10.1016/j.microc.2021.106407
DO - 10.1016/j.microc.2021.106407
M3 - 文章
AN - SCOPUS:85106377220
SN - 0026-265X
VL - 168
JO - Microchemical Journal
JF - Microchemical Journal
M1 - 106407
ER -